11-1390303-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001256627.2(BRSK2):c.19G>A(p.Asp7Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000356 in 1,039,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001256627.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRSK2 | NM_001256627.2 | c.19G>A | p.Asp7Asn | missense_variant | 1/20 | ENST00000528841.6 | NP_001243556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRSK2 | ENST00000528841.6 | c.19G>A | p.Asp7Asn | missense_variant | 1/20 | 1 | NM_001256627.2 | ENSP00000432000 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000748 AC: 11AN: 147126Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000291 AC: 26AN: 892340Hom.: 0 Cov.: 32 AF XY: 0.0000192 AC XY: 8AN XY: 416464
GnomAD4 genome AF: 0.0000747 AC: 11AN: 147210Hom.: 0 Cov.: 32 AF XY: 0.0000139 AC XY: 1AN XY: 71704
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.19G>A (p.D7N) alteration is located in exon 1 (coding exon 1) of the BRSK2 gene. This alteration results from a G to A substitution at nucleotide position 19, causing the aspartic acid (D) at amino acid position 7 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
BRSK2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 18, 2022 | The BRSK2 c.19G>A variant is predicted to result in the amino acid substitution p.Asp7Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-1411533-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at